Seeking Alpha

Lilly to acquire Adverum for up to $12.47 per share in cash and CVRs

Eli Lilly (NYSE:LLY) on Friday reported plans to acquire Adverum Biotechnologies (NASDAQ:ADVM) and its lead gene therapy candidate, Ixo-vec, sending Adverum shares soaring in premarket trading. Under ...
The Business Journals

Eli Lilly eyeing Philadelphia for Gateway Labs site, sources say

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Lilly's six existing Gateway ...
来自MSN

Eli Lilly Partners With Walmart To Expand Access To Popular Weight-loss Drug

・Zepbound vials will be offered for pick-up at Walmart pharmacies nationwide by mid-November. ・This marks LillyDirect’s first retail collaboration and is aimed at offering patients flexibility in how ...
Insider Monkey

Eli Lilly (LLY) Would Be Up More If The Market Weren’t That Bad, Says Jim Cramer

We recently published 10 Stocks on Jim Cramer’s Radar. Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently discussed. Eli Lilly and Company (NYSE:LLY) continues to be one of ...
Seeking Alpha

Eli Lilly, Novo reportedly nearing U.S. deals for obesity drug prices (update)

Weight-loss drugmakers Eli Lilly (LLY) and Novo Nordisk (NVO) (OTCPK:NONOF) are planning to announce new drug pricing deals with the White House, including for their blockbuster obesity therapies, ...
WFMZ-TV

Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war

FILE - This photo shows Novo Nordisk headquarters in Bagsvaerd, Denmark, on Feb. 5, 2025. (Mads Claus Rasmussen/Ritzau Scanpix via AP, File) FILE - This photo shows Novo Nordisk headquarters in ...
The Motley Fool

Down 15%, Should You Buy the Dip on Eli Lilly?

Eli Lilly is one of the largest drug companies in the world. The pharmaceutical giant's stock price is 15% below its 2024 high-water mark. Lilly's valuation numbers tell an important story if you're ...